Future Health ESG Revenue 2022-2023 | FHLT
Future Health ESG revenue from 2022 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Future Health ESG Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| Future Health ESG Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.000B |
| Future Health ESG Corp. entered into a definitive business combination agreement with Excelera DCE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.242B | 54.20 |
| Hims & Hers Health (HIMS) | United States | $14.325B | 148.84 |
| Tempus AI (TEM) | United States | $11.867B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.712B | 73.62 |
| IRhythm Technologies (IRTC) | United States | $4.463B | 0.00 |
| Privia Health (PRVA) | United States | $2.963B | 202.50 |
| Enovis (ENOV) | United States | $2.134B | 11.90 |
| Clover Health Investments (CLOV) | United States | $1.737B | 0.00 |
| Schrodinger (SDGR) | United States | $1.735B | 0.00 |
| Phreesia (PHR) | United States | $1.534B | 0.00 |
| Omnicell (OMCL) | United States | $1.312B | 23.14 |
| Azenta (AZTA) | United States | $1.277B | 59.36 |
| 10x Genomics (TXG) | United States | $1.180B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.589B | 0.00 |
| Talkspace (TALK) | United States | $0.514B | 153.50 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Standard BioTools (LAB) | United States | $0.433B | 0.00 |
| Claritev (CTEV) | United States | $0.405B | 0.00 |
| TruBridge (TBRG) | United States | $0.375B | 831.67 |
| Health Catalyst (HCAT) | United States | $0.299B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.208B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.197B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.156B | 0.00 |
| Pulmonx (LUNG) | United States | $0.133B | 0.00 |
| American Well (AMWL) | United States | $0.119B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.084B | 0.00 |
| CareCloud (CCLD) | United States | $0.084B | 3.19 |
| Retrieve Medical Holdings (RMHI) | United States | $0.083B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |